Jay Venkatesan - May 20, 2022 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: President and Chief Executive Officer and Director, Director
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Stock symbol: ELTX
Transactions as of: May 20, 2022
Transactions value $: $101,428
Form type: 4
Date filed: 5/25/2022, 05:58 PM
Previous filing: Mar 4, 2022
Next filing: May 27, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$61.5K	+50K	+3.05%	$1.23^*	1.69M	May 20, 2022	Direct
transaction	ELTX	Common Stock	Purchase	$39.9K	+32.2K	+1.91%	$1.24^*	1.72M	May 24, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

President and Chief Executive Officer and Director